TY - JOUR
T1 - Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
AU - Antonelli, Mariangela
AU - Sestito, Luisa
AU - Tarli, Claudia
AU - Addolorato, Giovanni
PY - 2022
Y1 - 2022
N2 - Introduction: In the last decades, many medications have been tested for the treatment of Alcohol Use Disorder (AUD). Among them, disulfiram, acamprosate, naltrexone, nalmefene, sodium oxybate and baclofen have been approved in different countries, with different specific indications. Topiramate is not approved for the treatment of AUD, however, it is suggested as a therapeutic option by the American Psychiatric Association for patients who do not tolerate or respond to approved therapies.Areas covered: In this narrative review we have analyzed the main studies available in literature, investigating the efficacy and safety of these medications, distinguishing whether they were oriented towards abstinence or not. Randomized controlled studies, analyzing larger populations for longer periods were the main focus of our analysis.Conclusions: The medications currently available for the treatment of AUD are quite effective, yet further progress can still be achieved through the personalized strategies. Also, these medications are still markedly underutilized in clinical practice and many patients do not have access to specialized treatment.
AB - Introduction: In the last decades, many medications have been tested for the treatment of Alcohol Use Disorder (AUD). Among them, disulfiram, acamprosate, naltrexone, nalmefene, sodium oxybate and baclofen have been approved in different countries, with different specific indications. Topiramate is not approved for the treatment of AUD, however, it is suggested as a therapeutic option by the American Psychiatric Association for patients who do not tolerate or respond to approved therapies.Areas covered: In this narrative review we have analyzed the main studies available in literature, investigating the efficacy and safety of these medications, distinguishing whether they were oriented towards abstinence or not. Randomized controlled studies, analyzing larger populations for longer periods were the main focus of our analysis.Conclusions: The medications currently available for the treatment of AUD are quite effective, yet further progress can still be achieved through the personalized strategies. Also, these medications are still markedly underutilized in clinical practice and many patients do not have access to specialized treatment.
KW - Acamprosate
KW - Alcohol use disorder
KW - Baclofen
KW - Disulfiram
KW - Topiramate
KW - Naltrexone
KW - Number needed to treat (NNT)
KW - Pharmacological treatment
KW - Nalmefene
KW - Acamprosate
KW - Alcohol use disorder
KW - Baclofen
KW - Disulfiram
KW - Topiramate
KW - Naltrexone
KW - Number needed to treat (NNT)
KW - Pharmacological treatment
KW - Nalmefene
UR - http://hdl.handle.net/10807/230549
U2 - 10.1016/j.ejim.2022.05.016
DO - 10.1016/j.ejim.2022.05.016
M3 - Article
SN - 0953-6205
VL - 103
SP - 13
EP - 22
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
ER -